These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 6315230)
21. Clinical anticancer pharmacology: some pharmacokinetic considerations. Levin VA Cancer Treat Rev; 1986 Jun; 13(2):61-76. PubMed ID: 3755652 [No Abstract] [Full Text] [Related]
22. Liposome-entrapped proteins in therapeutic and preventive medicine. Gregoriadis G Hindustan Antibiot Bull; 1977; 20(1-2):14-22. PubMed ID: 618084 [No Abstract] [Full Text] [Related]
23. Evaluation of hydroxyurea (NSC-32065) by parenteral infusion. Moertel CG; Reitemeier RJ; Hahn RG Cancer Chemother Rep; 1965 Dec; 49():27-9. PubMed ID: 5322837 [No Abstract] [Full Text] [Related]
24. [Infusion of methotrexate in the treatment of inoperable neoplasms of the lung]. Fesani F; Bobbio P Minerva Chir; 1966 Nov; 21(22):995-1000. PubMed ID: 5982933 [No Abstract] [Full Text] [Related]
25. Liposomes--problems and promise as selective drug carriers. Kaye SB Cancer Treat Rev; 1981 Mar; 8(1):27-50. PubMed ID: 7018681 [No Abstract] [Full Text] [Related]
26. [Characteristics of antineoplastic activity of some chemical compounds on the kinetic model of erythromyelosis in rats]. Emanuél' NM; Dronova NM; Erokhin VN; Belich EI Izv Akad Nauk SSSR Biol; 1968; 2():181-91. PubMed ID: 5261112 [No Abstract] [Full Text] [Related]
27. Intercostal vein infusion and perfusion cancer therapy. Setälä K Strahlentherapie; 1967 Nov; 134(3):376-80. PubMed ID: 5584680 [No Abstract] [Full Text] [Related]
28. Application of liposome-entrapped drugs. Kumashiro H; Mori N; Fukatsu T; Sato T Jpn J Psychiatry Neurol; 1986 Sep; 40(3):367-8. PubMed ID: 3106690 [No Abstract] [Full Text] [Related]
29. [The use of liposomes biotechnology in medical sciences]. Zhang RZ Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):367-9. PubMed ID: 3914376 [No Abstract] [Full Text] [Related]
30. [Supplement to the pathological study of erythroleucemia (case report)]. Kodama M Kumamoto Igakkai Zasshi; 1971 Oct; 45(10):945-63. PubMed ID: 5291351 [No Abstract] [Full Text] [Related]
31. [SELECTIVE INFUSIONS OF ANTIMITOTIC AGENTS IN OTORHINOLARYNGOLOGICAL NEOPLASMS]. ABBES M; AZZARO GC; PAILLAUD F; PRAT PP; SPRECHER R Mars Chir; 1965; 17():115-21. PubMed ID: 14336258 [No Abstract] [Full Text] [Related]
32. [PROPOSAL FOR THE TREATMENT OF SUBMESOCOLIC NEOPLASMS WITH ANTIMITOTIC AGENTS]. LAMY J; MICHOTEY G; BRICOT R; RODDE JM Mars Chir; 1965; 17():160-7. PubMed ID: 14336266 [No Abstract] [Full Text] [Related]
33. Feasibility of magnetic liposomes as a targeting device for drugs. Kiwada H; Sato J; Yamada S; Kato Y Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4253-8. PubMed ID: 3829157 [No Abstract] [Full Text] [Related]
34. [Resistance of tumors to antimitotic therapeutics]. Amiel JI Sem Ther; 1963 Nov; 39(9):583-7. PubMed ID: 5877598 [No Abstract] [Full Text] [Related]
35. Liposomes, Part G. Preface. Düzgüneş N Methods Enzymol; 2009; 465():xix. PubMed ID: 19913158 [No Abstract] [Full Text] [Related]
36. Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes. Zuidam NJ; Lee SS; Crommelin DJ Pharm Res; 1995 Nov; 12(11):1761-8. PubMed ID: 8592683 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation. Mishina EV; Straubinger RM; Pyszczynski NA; Jusko WJ Pharm Res; 1993 Oct; 10(10):1402-10. PubMed ID: 8272400 [TBL] [Abstract][Full Text] [Related]